We are live on ! Find out more
JC

Jacobs & Co Portfolio holdings

AUM $1.17B
1-Year Est. Return 37.3%
This Fund
S&P 500
This Quarter Est. Return
+11.82%
1 Year Est. Return
+37.3%
3 Year Est. Return
+92.23%
5 Year Est. Return
+114.23%
10 Year Est. Return
+410.55%
AUM
$689M
AUM Growth
+$74.9M
Cap. Flow
+$11.8M
Cap. Flow %
1.71%
Top 10 Hldgs %
30.12%
Holding
115
New
3
Increased
36
Reduced
53
Closed
4

Top Buys

Rank Stock Value
1
ADP icon
Automatic Data Processing
ADP
+$4.35M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.61M
3
PFE icon
Pfizer
PFE
+$2.57M
4
ENB icon
Enbridge
ENB
+$1.74M
5
GSK icon
GSK
GSK
+$1.64M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$2.21M
2
PYPL icon
PayPal
PYPL
+$1.14M
3
AMZN icon
Amazon
AMZN
+$1M
4
WBA
Walgreens Boots Alliance
WBA
+$838K
5
ADBE icon
Adobe
ADBE
+$728K

Sector Composition

Rank Sector Weight
1 Technology 23.26%
2 Healthcare 19.26%
3 Industrials 14.55%
4 Consumer Discretionary 12.35%
5 Communication Services 10.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMAT icon
51
Applied Materials
AMAT
$403B
$6.02M 0.87%
101,341
+10,874
+12% +$672K
CMI icon
52
Cummins
CMI
$87.5B
$5.88M 0.85%
27,856
-355
-1% -$70.7K
GOOGL icon
53
Alphabet (Google) Class A
GOOGL
$4.36T
$5.58M 0.81%
76,200
+20
+0% +$1.52K
YUM icon
54
Yum! Brands
YUM
$41.8B
$5.53M 0.8%
60,542
+4,778
+9% +$440K
EA icon
55
Electronic Arts
EA
$53B
$5.45M 0.79%
41,777
+235
+0.6% +$32K
GSK icon
56
GSK
GSK
$104B
$5.42M 0.79%
115,102
+32,748
+40% +$1.64M
LH icon
57
Labcorp
LH
$25B
$5.2M 0.75%
32,156
+47
+0.1% +$7.45K
REGN icon
58
Regeneron Pharmaceuticals
REGN
$78.5B
$5.1M 0.74%
9,108
+4,304
+90% +$2.61M
ZBH icon
59
Zimmer Biomet
ZBH
$18.2B
$4.74M 0.69%
35,894
-487
-1% -$63.6K
LLY icon
60
Eli Lilly
LLY
$1.02T
$4.57M 0.66%
30,896
-1,668
-5% -$258K
MDT icon
61
Medtronic
MDT
$109B
$4.4M 0.64%
42,329
+30
+0.1% +$3.01K
AXP icon
62
American Express
AXP
$227B
$4.11M 0.6%
41,030
+822
+2% +$80.9K
INTU icon
63
Intuit
INTU
$86.5B
$3.82M 0.55%
11,700
-500
-4% -$156K
MDLZ icon
64
Mondelez International
MDLZ
$79.5B
$3.72M 0.54%
64,734
-225
-0.3% -$12.5K
BUD icon
65
AB InBev
BUD
$170B
$3.68M 0.53%
68,391
-449
-0.7% -$24.9K
HUBB icon
66
Hubbell
HUBB
$25B
$3.5M 0.51%
25,565
+425
+2% +$58.5K
BAX icon
67
Baxter International
BAX
$13.5B
$3.43M 0.5%
42,624
+742
+2% +$62.4K
DT
68
DELISTED
DEUTSCHE TELEKOM AG ADS (1ORD)
DT
$3.41M 0.49%
202,471
-1,650
-0.8% -$27.8K
BRK.B icon
69
Berkshire Hathaway Class B
BRK.B
$1.1T
$3.04M 0.44%
14,270
-1,544
-10% -$316K
TGT icon
70
Target
TGT
$65.6B
$2.59M 0.38%
16,455
-485
-3% -$66.5K
CVX icon
71
Chevron
CVX
$392B
$2.55M 0.37%
35,373
-4,464
-11% -$375K
SNA icon
72
Snap-on
SNA
$21.2B
$2.23M 0.32%
15,185
EMR icon
73
Emerson Electric
EMR
$83.9B
$2.1M 0.31%
32,061
NXPI icon
74
NXP Semiconductors
NXPI
$57.8B
$2.08M 0.3%
16,649
-133
-0.8% -$16.2K
GILD icon
75
Gilead Sciences
GILD
$162B
$1.77M 0.26%
27,949
+5,595
+25% +$388K

Similar funds

Jacobs & Co's Q3 2020 Portfolio in Review

As of Q3 2020, Jacobs & Co held 115 positions worth $689M, up 12% from $614M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jacobs & Co's Q3 2020 filing shows 3 new, 36 increased, 53 reduced and 4 closed positions. Its largest new stake was O'Reilly Automotive: 6,600 shares worth $202K. The largest sale was Apple, an estimated $2.21M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.

  • Jacobs & Co's largest Q3 2020 buy was O'Reilly Automotive: 6,600 shares worth $202K.
  • Jacobs & Co added most to Automatic Data Processing in Q3 2020, an estimated $4.35M increase.
  • Jacobs & Co's biggest Q3 2020 reduction was Apple, cutting an estimated $2.21M.
  • Jacobs & Co fully exited HP in Q3 2020, selling an estimated $302K.
  • Jacobs & Co's ten largest holdings make up 30% of its $689M portfolio in Q3 2020.
  • Jacobs & Co opened 3 new positions and closed 4 in Q3 2020.
  • Jacobs & Co's portfolio value rose 12% quarter-over-quarter to $689M.

Based on Jacobs & Co's 13F filing for Q3 2020, filed 3 Dec 2020.